Repertoire Immune Medicines

Repertoire Immune Medicines is a Cambridge, Massachusetts biotechnology company (with a site in Schlieren, Switzerland) building immune medicines grounded in the human T cell repertoire. Its proprietary DECODE platform characterizes the immune synapse by identifying T cell receptor (TCR) and antigen (peptide-MHC) pairs together with T cell function and HLA presentation, and uses that map to rationally design treatments across oncology, autoimmune disease, and infectious disease. Backed by Flagship Pioneering and SoftBank Vision Fund, the company was surfaced as a portfolio company and added to the API Evangelist network for enrichment. It publishes no public developer API; its only public technical surface is a small research GitHub organization.

Repertoire Immune Medicines is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Immunology, and T Cell.

Repertoire Immune Medicines’ developer surface includes engineering blog, support, and 5 more developer resources.

13.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealth TechBiotechnologyImmunologyT CellDrug DiscoveryOncology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 13.0/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.7 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/repertoire-immune-medicines: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Repertoire Immune Medicines Domain Security

TLSv1.3 · DNSSEC · DMARC

SECURITY

Resources

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: repertoire-immune-medicines
name: Repertoire Immune Medicines
description: Repertoire Immune Medicines is a Cambridge, Massachusetts biotechnology company (with a site in Schlieren, Switzerland)
  building immune medicines grounded in the human T cell repertoire. Its proprietary DECODE platform characterizes the immune
  synapse by identifying T cell receptor (TCR) and antigen (peptide-MHC) pairs together with T cell function and HLA presentation,
  and uses that map to rationally design treatments across oncology, autoimmune disease, and infectious disease. Backed by
  Flagship Pioneering and SoftBank Vision Fund, the company was surfaced as a portfolio company and added to the API Evangelist
  network for enrichment. It publishes no public developer API; its only public technical surface is a small research GitHub
  organization.
url: https://raw.githubusercontent.com/api-evangelist/repertoire-immune-medicines/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Health Tech
- Biotechnology
- Immunology
- T Cell
- Drug Discovery
- Oncology
image: https://www.repertoire.com/favicon.ico
apis: []
common:
- type: DomainSecurity
  url: security/repertoire-immune-medicines-domain-security.yml
- type: Website
  url: https://www.repertoire.com/
- type: GitHubOrganization
  url: https://github.com/repertoireimmunemedicines
- type: Blog
  url: https://www.repertoire.com/about/press-releases
- type: Support
  url: https://www.repertoire.com/contact
- type: PrivacyPolicy
  url: https://www.repertoire.com/privacy
- type: TermsOfService
  url: https://www.repertoire.com/terms
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 2
  pass: local-v1